Chinese english Germany Japanese Korea

(S)-3-(4,6-dichloropyrimidin-2-yl)-5,6-dihydro-4H-spiro[benzo[d]isoxazole-7,1'-cyclohexan]-2'-one

(S)-3-(4,6-dichloropyrimidin-2-yl)-5,6-dihydro-4H-spiro[benzo[d]isoxazole-7,1'-cyclohexan]-2'-one Struktur
2936672-10-3
CAS-Nr.
2936672-10-3
Englisch Name:
(S)-3-(4,6-dichloropyrimidin-2-yl)-5,6-dihydro-4H-spiro[benzo[d]isoxazole-7,1'-cyclohexan]-2'-one
Synonyma:
Krass intermediate 01;(S)-3-(4,6-Dichloro-2-pyrimidinyl)-5,6-dihydro-4H-spiro[benzo[d]isoxazole-7,1’-cyclohexan]-2’-one;(S)-3-(4,6-dichloropyrimidin-2-yl)-5,6-dihydro-4H-spiro[benzo[d]isoxazole-7,1'-cyclohexan]-2'-one
CBNumber:
CB213735991
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file
Request For Quotation

(S)-3-(4,6-dichloropyrimidin-2-yl)-5,6-dihydro-4H-spiro[benzo[d]isoxazole-7,1'-cyclohexan]-2'-one Eigenschaften

Sicherheit

(S)-3-(4,6-dichloropyrimidin-2-yl)-5,6-dihydro-4H-spiro[benzo[d]isoxazole-7,1'-cyclohexan]-2'-one Chemische Eigenschaften,Einsatz,Produktion Methoden

(S)-3-(4,6-dichloropyrimidin-2-yl)-5,6-dihydro-4H-spiro[benzo[d]isoxazole-7,1'-cyclohexan]-2'-one Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

(S)-3-(4,6-dichloropyrimidin-2-yl)-5,6-dihydro-4H-spiro[benzo[d]isoxazole-7,1'-cyclohexan]-2'-one Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Accela ChemBio Inc. 		+1-858-6993322
info@accelachem.com United States 19447 58
hubei PharmaStandard Co., Ltd. 027-19050701 13545374703
 cbbspring@163.com China 371 58
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd. 025-66113011 18112977050
 cb5@aikonchem.com China 10529 58
Accela ChemBio Co.,Ltd. 021-50795510 4000665055
 SY06@accelachem.com China 10313 58
  • (S)-3-(4,6-dichloropyrimidin-2-yl)-5,6-dihydro-4H-spiro[benzo[d]isoxazole-7,1'-cyclohexan]-2'-one
  • Krass intermediate 01
  • (S)-3-(4,6-Dichloro-2-pyrimidinyl)-5,6-dihydro-4H-spiro[benzo[d]isoxazole-7,1’-cyclohexan]-2’-one
  • 2936672-10-3
Copyright 2019 © ChemicalBook. All rights reserved